Polygenic Risk Score Studies Suggest Conventional Heart Disease Prediction Methods Still Preferable

Feb 18, 2020

|

NEW YORK – A pair of new studies suggests that polygenic risk scores (PRS) for coronary artery disease (CAD) such as myocardial infarction might offer some predictive improvement when added to conventional clinical evaluation approaches, though genetic scores alone do not appear to have the predictive wherewithal to replace existing strategies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Open Spot

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.

Featured White Papers

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

Expanded Droplet Digital PCR Multiplexing Capability Using Two Different Strategies

Decoding Carrier Screening

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Feb

18

Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.

Feb

25

Featured Webinar

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

In this session, the second in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review cases in which patient genomic profiles exhibit common driver mutations in tumor types considered “off label” for targeted therapies associated with those mutations.

Menu

Polygenic Risk Score Studies Suggest Conventional Heart Disease Prediction Methods Still Preferable

To read the full story....

Breaking News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Skin Cell Atlas Elucidates Pathological Cell States Underlying Inflammatory Skin Diseases

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

Genetic Technologies to Raise $6.6M in Direct Offering

CareDx Prices $175M Common Stock Offering

The Scan

Open Spot

US to Remain in WHO

Dip Possible

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

What's Popular?

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Sponsorships